Journal
EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 17, Issue 7, Pages 890-896Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ejhg.2008.253
Keywords
EQA/PT; molecular diagnosis; hereditary recurrent fevers
Funding
- French Ministry of Health
- Centre Hospitalo-Universitaire de Montpellier
- European Community's
Ask authors/readers for more resources
Hereditary recurrent fevers (HRF) are rare diseases caused by molecular defects in genes involved in the regulation of innate immunity. Sixty-seven international laboratories participated in an external quality assessment (EQA) scheme, which was developed to appraise the accuracy of genetic testing. Reports were evaluated for the 12 items recommended by the OECD (Organisation for Economic Co-Operation and Development) guidelines for molecular diagnostics. The best documented items were the name of the gene, the biologist, or the patient, whereas information on the test and screening limits, and clinical interpretation of the disease inheritance were scarcely provided. The mutation nomenclature was incomplete in about 70% of the cases. In the first 2 years of EQA, we identified almost 30% genotyping error rate, which decreased markedly in the last year. The combined performance on the basis of the correct identification of all genotypes by a given laboratory in all the 3 years was only 40%, showing a critical need for improvement. European Journal of Human Genetics (2009) 17, 890-896; doi:10.1038/ejhg.2008.253; published online 28 January 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available